KIF18A Inhibitor Clinical Trials FDA Approved KIF18A Targeting Therapies Market Report
Delhi, June 24, 2025 (GLOBE NEWSWIRE) -- Global KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025 Report Highlights & Findings:
First KIF18A Targeting Therapy Commercial Availability Expected By 2030
Highest Phase Of Development: Phase-I/II
KIF18A Targeting Therapies In Clinical Trials: > 10 Therapies
KIF18A Targeting Therapies Clinical Trials Insight By Company, Country, Indication & Phase
KIF18A Targeting Therapies Market Development Trends Insight
KIF18A Therapies Technology Platforms Insight
Download Report: https://www.kuickresearch.com/report-kif18a-targeting-inhibitor-kif18a-inhibitor-clinical-trials-kif18a-targeting-therapy
The global oncology landscape is witnessing rapid progress in precision medicine, and one of the most lead nominees in emerging targets is Kinesin Family Member 18A (KIF18A). It is a mitotic motor protein that is essential for chromosome alignment during mitosis, which facilitates proper segregation of chromosomes. Its perturbation leads to genomic instability, which is a distinguishing feature of cancer. Extrapolations of KIF18A have also been seen in various cancers such as ovarian and breast cancer, with an association with prognosis, drug resistance, and the potential to metastasize. As a crucial protein involved in mitosis and overexpression in cancer, KIF18A is now a promising therapeutic target.
Targeting KIF18A interferes with mitotic mechanisms in chromosomally unstable (CIN-positive) cancer cells, causing selective death of cancer cells. In contrast to conventional chemotherapies, which indiscriminately impact all proliferating cells, KIF18A inhibitors provide a more selective and less toxic option by taking advantage of cancer cells' vulnerability to proper mitosis. The major approach is small molecule inhibitors that disrupt KIF18A's motor activity, hindering it from modulating microtubule dynamics at the kinetochore. It leads to mitotic arrest and failure of chromosome alignment, ultimately triggering apoptosis in cancer cells.
Clinical development is progressing well. Volastra Therapeutics, a forerunner in this arena, is developing two KIF18A-targeting molecules: Sovilnesib (AMG650), acquired from Amgen and underway in Phase I trials for platinum-resistant high-grade serous ovarian cancer, and VLS-1488, an in-house oral inhibitor in Phase I/II. Both molecules displayed favorable safety profiles and early anti-tumor effects, with particular efficacy in high-chromosomal-instability tumors. Volastra's pipeline demonstrates the therapeutic potential of inhibiting KIF18A to treat difficult-to-treat cancers.
Accent Therapeutics is also advancing with ATX-295, an oral KIF18A inhibitor in initial clinical testing for solid tumors such as triple-negative breast and high-grade serous ovarian cancers. Their biomarker strategy makes use of genomic instability markers such as whole-genome doubling to better optimize patient selection and optimize therapy outcomes.
AI based drug discovery is providing additional impetus to this area. Insilico Medicine has utilized proprietary platforms such as Chemistry42 and PandaOmics to discover ISM9682, a new macrocyclic KIF18A inhibitor with high preclinical efficacy. The AI platforms facilitate rapid optimization of candidates with increased specificity and pharmacological profiles, highlighting the growing use of sophisticated computational approaches in drug discovery.
Aside from clinical advancement, the market opportunity for KIF18A inhibitors is also robust. As precision oncology gains more attention, the therapies are well poised to capture the opportunity of targeted therapies, particularly in diseases that are refractory to current treatments. Various companies, including Nvidia-funded Iambic Therapeutics, Aurigene Oncology, Simcere Zaiming Pharmaceutical, and Amgen, are developing promising product candidates in preclinical phases.
Overall, the KIF18A-targeted therapy market is changing very quickly, powered by strong scientific justification, initial clinical success, and novel development approaches. As additional preclinical and clinical information becomes available, the market has significant potential for strong growth, powered by partnerships, application of artificial intelligence and machine learning tactics, and the overall dedication to creating targeted and individualized cancer therapeutics.
CONTACT: Neeraj Chawla Research Head Kuick Research neeraj@kuickresearch.com https://www.kuickresearch.com/Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Owning 66% in UWC Berhad (KLSE:UWC) means that insiders are heavily invested in the company's future
Key Insights Significant insider control over UWC Berhad implies vested interests in company growth 64% of the business is held by the top 2 shareholders Institutions own 23% of UWC Berhad This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. If you want to know who really controls UWC Berhad (KLSE:UWC), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 66% to be precise, is individual insiders. Put another way, the group faces the maximum upside potential (or downside risk). So, insiders of UWC Berhad have a lot at stake and every decision they make on the company's future is important to them from a financial point of view. In the chart below, we zoom in on the different ownership groups of UWC Berhad. View our latest analysis for UWC Berhad What Does The Institutional Ownership Tell Us About UWC Berhad? Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing. We can see that UWC Berhad does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of UWC Berhad, (below). Of course, keep in mind that there are other factors to consider, too. UWC Berhad is not owned by hedge funds. The company's CEO Chai Ng is the largest shareholder with 32% of shares outstanding. For context, the second largest shareholder holds about 32% of the shares outstanding, followed by an ownership of 8.3% by the third-largest shareholder. Interestingly, the second-largest shareholder, Chee Lau is also Chief Operating Officer, again, pointing towards strong insider ownership amongst the company's top shareholders. A more detailed study of the shareholder registry showed us that 2 of the top shareholders have a considerable amount of ownership in the company, via their 64% stake. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too. Insider Ownership Of UWC Berhad While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Our information suggests that insiders own more than half of UWC Berhad. This gives them effective control of the company. Given it has a market cap of RM2.4b, that means they have RM1.6b worth of shares. Most would be pleased to see the board is investing alongside them. You may wish todiscover (for free) if they have been buying or selling. General Public Ownership With a 11% ownership, the general public, mostly comprising of individual investors, have some degree of sway over UWC Berhad. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. Next Steps: It's always worth thinking about the different groups who own shares in a company. But to understand UWC Berhad better, we need to consider many other factors. Take risks for example - UWC Berhad has 2 warning signs (and 1 which is a bit concerning) we think you should know about. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
3 minutes ago
- Yahoo
Agoda launches first-ever brand campaign in Singapore with AI-powered commercials
SINGAPORE, July 22, 2025 /PRNewswire/ -- Digital travel platform Agoda launched its first-ever brand campaign in Singapore, centred around an AI-powered commercials that spotlights the company's flights offering in Singaporean fashion. Building on the success of Agoda's previous AI-led activations in India, this latest campaign leverages cutting-edge AI video generation platforms like Google Veo, Runway, and Kling AI to produce a film that spotlights the value of booking flights on Agoda's platform, but with a distinctly Singaporean touch. Aside from the in-house ideation and voice-over recording, all the visual elements of the creative were created using the latest generative AI technology. "Singapore, Agoda's home base and a global aviation hub, couldn't be a better place to kick off our flights-focused campaign," said Matteo Frigerio, Chief Marketing Officer at Agoda. "Agoda has long been synonymous with amazing accommodation deals, and now, with our first-ever brand campaign in Singapore, we're turning the spotlight on our incredible airfare offers. Powered by cutting-edge generative AI, we're showing travellers that Agoda is the ultimate destination for innovation and unbeatable value, all starting right here in Singapore!" The AI-powered commercial videos are live now on digital channels YouTube and Meta. The campaign is supplemented by a multi-channel social media strategy that spans YouTube, Meta, and TikTok. The campaign highlights Agoda's great value flight deals, with flights from Singapore starting at just SGD 39. The commercials are now live and can be viewed here and here. View original content to download multimedia: SOURCE Agoda Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 minutes ago
- Yahoo
Singapore Airlines Enhances Customer Experience Analytics with Qualtrics
SINGAPORE, July 21, 2025 /PRNewswire/ -- Qualtrics, the leader and creator of the experience management category, today announced that Singapore Airlines (SIA) is using its solutions to enhance its collection, processing, and analysis of customer responses, enabling deeper insights across multiple feedback channels. The three-year agreement supports SIA's efforts to better understand customer concerns and preferences through research, data analytics, and artificial intelligence (AI). This approach allows SIA to gather comprehensive customer experience data across multiple channels, helping identify evolving preferences and address concerns across various touchpoints. "Singapore Airlines uses Qualtrics' text analytics to process and analyse customer feedback from multiple channels. By integrating advanced analytics with our customer experience strategies, we can better understand our customers' evolving expectations, address their needs more effectively, and enhance their end-to-end journey with Singapore Airlines," said Melvin Ng, Vice President of Customer Experience at Singapore Airlines. SIA is also exploring how to leverage Qualtrics' GenAI capabilities to enhance analysis of open-ended customer feedback. This would help the airline extract more meaningful insights from written comments and suggestions to improve the customer travel journey. "Companies that deliver great experiences build deeper relationships with their customers, and today's market leaders are proven to have made this a greater priority over the last three years," said Brad Anderson, President at Qualtrics. "As consumer feedback habits evolve, thousands of leading organisations across the world, including Singapore Airlines, are using Qualtrics to understand and improve their customer experience with omnichannel insights captured across the customer journey. These rich insights provide companies with intelligence and capabilities they need to win now and in the coming era of agentic AI," Anderson concluded. About Singapore AirlinesThe Singapore Airlines (SIA) Group's history dates to 1947 with the maiden flight of Malayan Airways. The airline was later renamed Malaysian Airways and then Malaysia-Singapore Airlines (MSA). In 1972, MSA split into Singapore Airlines and Malaysian Airline System. Initially operating a modest fleet of 10 aircraft to 22 destinations in 18 countries, SIA has since grown to be a world-class international airline group that is committed to the constant enhancement of the three main pillars of its brand promise: Service Excellence, Product Leadership, and Network Connectivity. Singapore Airlines is the world's most awarded airline. For more information, please visit About QualtricsQualtrics is trusted by thousands of the world's best organizations to power exceptional customer and employee experiences that build deep human connections, increase customer loyalty, boost employee engagement, and drive business success. Our advanced AI and specialized Experience Agents allow businesses and governments to proactively interact with customers and employees in personalized ways across every channel and touchpoint, respond in-the-moment to fix or improve experiences, and stay across the latest market trends and opportunities. Contact: Tahra De Souza Lane, press@ View original content to download multimedia: SOURCE Qualtrics, LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
